{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:48:55Z","timestamp":1793753335472,"version":"4.6.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In recent decades, chikungunya virus (CHIKV) has re-emerged, leading to outbreaks of chikungunya fever in Africa, Asia and Central and South America. The disease is characterized by a rapid onset febrile illness with (poly)arthralgia, myalgia, rashes, headaches and nausea. In 30 to 40% of the cases, CHIKV infection causes persistent (poly)arthralgia, lasting for months or even years after initial infection. Despite the drastic re-emergence and clinical impact there is no vaccine nor antiviral compound available to prevent or control CHIKV infection. Here, we evaluated the antiviral potential of tomatidine towards CHIKV infection. We demonstrate that tomatidine potently inhibits virus particle production of multiple CHIKV strains. Time-of -addition experiments in Huh7 cells revealed that tomatidine acts at a post-entry step of the virus replication cycle. Furthermore, a marked decrease in the number of CHIKV-infected cells was seen, suggesting that tomatidine predominantly acts early in infection yet after virus attachment and cell entry. Antiviral activity was still detected at 24\u2009hours post-infection, indicating that tomatidine controls multiple rounds of CHIKV replication. Solasodine and sarsasapogenin, two structural derivatives of tomatidine, also showed strong albeit less potent antiviral activity towards CHIKV. In conclusion, this study identifies tomatidine as a novel compound to combat CHIKV infection <jats:italic>in vitro<\/jats:italic>.<\/jats:p>","DOI":"10.1038\/s41598-020-63397-7","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T10:03:12Z","timestamp":1586858592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Tomatidine, a natural steroidal alkaloid shows antiviral activity towards chikungunya virus in vitro"],"prefix":"10.1038","volume":"10","author":[{"given":"Berit","family":"Troost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne M.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6693-3474","authenticated-orcid":false,"given":"Mayra","family":"Diosa-Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"van de Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela A.","family":"Rodenhuis-Zybert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda M.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,14]]},"reference":[{"key":"63397_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/0035-9203(55)90080-8","volume":"49","author":"MC Robinson","year":"1955","unstructured":"Robinson, M. C. An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952\u20131953. Trans. R. Soc. Trop. Med. Hyg. 49, 28\u201332 (1955).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"63397_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.antiviral.2013.06.009","volume":"99","author":"S-D Thiberville","year":"2013","unstructured":"Thiberville, S.-D. et al. Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res. 99, 345\u2013370 (2013).","journal-title":"Antiviral Res."},{"key":"63397_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1056\/NEJMra1406035","volume":"372","author":"SC Weaver","year":"2015","unstructured":"Weaver, S. C. & Lecuit, M. Chikungunya Virus and the Global Spread of a Mosquito-Borne Disease. N. Engl. J. Med. 372, 1231\u20131239 (2015).","journal-title":"N. Engl. J. Med."},{"key":"63397_CR4","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1086\/517537","volume":"44","author":"G Borgherini","year":"2007","unstructured":"Borgherini, G. et al. Outbreak of Chikungunya on Reunion Island: Early Clinical and Laboratory Features in 157 Adult Patients. Clin. Infect. Dis. 44, 1401\u20131407 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"63397_CR5","doi-asserted-by":"publisher","first-page":"e0006510","DOI":"10.1371\/journal.pntd.0006510","volume":"12","author":"D Contopoulos-Ioannidis","year":"2018","unstructured":"Contopoulos-Ioannidis, D., Newman-Lindsay, S., Chow, C. & LaBeaud, A. D. Mother-to-child transmission of Chikungunya virus: A systematic review and meta-analysis. PLoS Negl. Trop. Dis. 12, e0006510 (2018).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"63397_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.antiviral.2017.12.012","volume":"150","author":"A Oo","year":"2018","unstructured":"Oo, A. et al. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection. Antiviral Res. 150, 101\u2013111 (2018).","journal-title":"Antiviral Res."},{"key":"63397_CR7","first-page":"1","volume":"4","author":"E Gould","year":"2017","unstructured":"Gould, E., Pettersson, J., Higgs, S., Charrel, R. & de Lamballerie, X. Emerging arboviruses: Why today? One Heal. (Amsterdam, Netherlands) 4, 1\u201313 (2017).","journal-title":"One Heal. (Amsterdam, Netherlands)"},{"key":"63397_CR8","doi-asserted-by":"crossref","unstructured":"Gal\u00e1n-Huerta, K. A. et al. Molecular and Clinical Characterization of Chikungunya Virus Infections in Southeast Mexico. Viruses 10 (2018).","DOI":"10.3390\/v10050248"},{"key":"63397_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fcimb.2018.00345","volume":"8","author":"ISB Tanabe","year":"2018","unstructured":"Tanabe, I. S. B. et al. Cellular and Molecular Immune Response to Chikungunya Virus Infection. Front. Cell. Infect. Microbiol. 8, 345 (2018).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"63397_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrmicro2368","volume":"8","author":"O Schwartz","year":"2010","unstructured":"Schwartz, O. & Albert, M. L. Biology and pathogenesis of chikungunya virus. Nat. Rev. Microbiol. 8, 491\u2013500 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"63397_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep11421","volume":"5","author":"R Lani","year":"2015","unstructured":"Lani, R. et al. Antiviral activity of silymarin against chikungunya virus. Sci. Rep. 5, 11421 (2015).","journal-title":"Sci. Rep."},{"key":"63397_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.antiviral.2017.09.016","volume":"149","author":"R Abdelnabi","year":"2018","unstructured":"Abdelnabi, R., Jochmans, D., Verbeken, E., Neyts, J. & Delang, L. Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection. Antiviral Res. 149, 113\u2013117 (2018).","journal-title":"Antiviral Res."},{"key":"63397_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.antiviral.2015.12.012","volume":"126","author":"FS Varghese","year":"2016","unstructured":"Varghese, F. S. et al. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses. Antiviral Res. 126, 117\u2013124 (2016).","journal-title":"Antiviral Res."},{"key":"63397_CR14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cbi.2013.03.016","volume":"203","author":"K-H Yan","year":"2013","unstructured":"Yan, K.-H. et al. Tomatidine inhibits invasion of human lung adenocarcinoma cell A549 by reducing matrix metalloproteinases expression. Chem. Biol. Interact. 203, 580\u2013587 (2013).","journal-title":"Chem. Biol. Interact."},{"key":"63397_CR15","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1016\/j.febslet.2008.05.049","volume":"582","author":"FL Chiu","year":"2008","unstructured":"Chiu, F. L. & Lin, J. K. Tomatidine inhibits iNOS and COX-2 through suppression of NF-\u03baB and JNK pathways in LPS-stimulated mouse macrophages. FEBS Lett. 582, 2407\u20132412 (2008).","journal-title":"FEBS Lett."},{"key":"63397_CR16","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1128\/AAC.01468-10","volume":"55","author":"G Mitchell","year":"2011","unstructured":"Mitchell, G. et al. Tomatidine Inhibits Replication of Staphylococcus aureus Small-Colony Variants in Cystic Fibrosis Airway Epithelial Cells. Antimicrob. Agents Chemother. 55, 1937\u20131945 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"63397_CR17","doi-asserted-by":"crossref","unstructured":"Boulet, M. L. et al. Tomatidine is a lead antibiotic molecule that targets staphylococcus aureus ATP Synthase subunit C. Antimicrob. Agents Chemother. 62 (2018).","DOI":"10.1128\/AAC.02197-17"},{"key":"63397_CR18","doi-asserted-by":"crossref","unstructured":"Guay, I. et al. Tomatidine and analog FC04-100 possess bactericidal activities against Listeria, Bacillus and Staphylococcus spp. BMC Pharmacol. Toxicol. 19 (2018).","DOI":"10.1186\/s40360-018-0197-2"},{"key":"63397_CR19","doi-asserted-by":"publisher","first-page":"14913","DOI":"10.1074\/jbc.M114.556241","volume":"289","author":"MC Dyle","year":"2014","unstructured":"Dyle, M. C. et al. Systems-based discovery of tomatidine as a natural small molecule inhibitor of skeletal muscle atrophy. J. Biol. Chem. 289, 14913\u201314924 (2014).","journal-title":"J. Biol. Chem."},{"key":"63397_CR20","first-page":"3","volume":"13","author":"D Jain","year":"1990","unstructured":"Jain, D., Khan, A. A., Zaim, M. & Thakur, M. R. Antiviral evaluations of some steroids and their glycosides: a new report. National Academy Science Letters 13, 3\u20134 (1990).","journal-title":"National Academy Science Letters"},{"key":"63397_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.antiviral.2018.11.011","volume":"161","author":"M Diosa-Toro","year":"2019","unstructured":"Diosa-Toro, M. et al. Tomatidine, a novel antiviral compound towards dengue virus. Antiviral Res. 161, 90\u201399 (2019).","journal-title":"Antiviral Res."},{"key":"63397_CR22","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1093\/jac\/dku209","volume":"69","author":"L Delang","year":"2014","unstructured":"Delang, L. et al. Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral. J. Antimicrob. Chemother. 69, 2770\u20132784 (2014).","journal-title":"J. Antimicrob. Chemother."},{"key":"63397_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.virol.2017.02.014","volume":"505","author":"Y Wada","year":"2017","unstructured":"Wada, Y. et al. Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus. Virology 505, 102\u2013112 (2017).","journal-title":"Virology"},{"key":"63397_CR24","doi-asserted-by":"publisher","first-page":"69421","DOI":"10.1039\/C6RA16640G","volume":"6","author":"A Ahmadi","year":"2016","unstructured":"Ahmadi, A. et al. Inhibition of chikungunya virus replication by hesperetin and naringenin. RSC Adv. 6, 69421\u201369430 (2016).","journal-title":"RSC Adv."},{"key":"63397_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/v11020175","volume":"11","author":"G Matusali","year":"2019","unstructured":"Matusali, G. et al. Tropism of the Chikungunya Virus. Viruses 11, 175 (2019).","journal-title":"Viruses"},{"key":"63397_CR26","doi-asserted-by":"crossref","unstructured":"Franco, E. J., Rodriquez, J. L., Pomeroy, J. J., Hanrahan, K. C. & Brown, A. N. The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines. Antivir. Chem. Chemother. 26 (2018).","DOI":"10.1177\/2040206618807580"},{"key":"63397_CR27","doi-asserted-by":"crossref","unstructured":"John Cruz, D. M. et al. Identification of Novel Compounds Inhibiting Chikungunya Virus-Induced Cell Death by High Throughput Screening of a Kinase Inhibitor Library. Plos Negl. Trop. Dis. 7 (2013).","DOI":"10.1371\/journal.pntd.0002471"},{"key":"63397_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.antiviral.2018.11.017","volume":"161","author":"J Hwang","year":"2019","unstructured":"Hwang, J., Jiang, A. & Fikrig, E. A potent prolyl tRNA synthetase inhibitor antagonizes Chikungunya and Dengue viruses. Antiviral Res. 161, 163\u2013168 (2019).","journal-title":"Antiviral Res."},{"key":"63397_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.antiviral.2016.07.025","volume":"134","author":"S-C Kuo","year":"2016","unstructured":"Kuo, S.-C. et al. Suramin treatment reduces chikungunya pathogenesis in mice. Antiviral Res. 134, 89\u201396 (2016).","journal-title":"Antiviral Res."},{"key":"63397_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.antiviral.2016.10.003","volume":"135","author":"YM Wang","year":"2016","unstructured":"Wang, Y. M. et al. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission. Antiviral Res. 135, 81\u201390 (2016).","journal-title":"Antiviral Res."},{"key":"63397_CR31","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Qui\u00f1onez, J. A. et al. Complete genome sequences of chikungunya virus strains isolated in Mexico: first detection of imported and autochthonous cases. Genome Announc. 3 (2015).","DOI":"10.1128\/genomeA.00300-15"},{"key":"63397_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1017\/S0022172400044454","volume":"54","author":"RW Ross","year":"1956","unstructured":"Ross, R. W. A laboratory technique for studying the insect transmission of animal viruses, employing a bat-wing membrane, demonstrated with two African viruses. J. Hyg. (Lond). 54, 192\u2013200 (1956).","journal-title":"J. Hyg. (Lond)."},{"key":"63397_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.antiviral.2015.06.013","volume":"121","author":"IC Albulescu","year":"2015","unstructured":"Albulescu, I. C. et al. Suramin inhibits chikungunya virus replication through multiple mechanisms. Antiviral Res. 121, 39\u201346 (2015).","journal-title":"Antiviral Res."},{"key":"63397_CR34","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.bmc.2018.01.002","volume":"26","author":"R Tardugno","year":"2018","unstructured":"Tardugno, R. et al. Design, synthesis and evaluation against Chikungunya virus of novel small-molecule antiviral agents. Bioorganic Med. Chem. 26, 869\u2013874 (2018).","journal-title":"Bioorganic Med. Chem."},{"key":"63397_CR35","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ejmech.2013.11.019","volume":"80","author":"F Chagnon","year":"2014","unstructured":"Chagnon, F. et al. Unraveling the structure\u2013activity relationship of tomatidine, a steroid alkaloid with unique antibiotic properties against persistent forms of Staphylococcus aureus. Eur. J. Med. Chem. 80, 605\u2013620 (2014).","journal-title":"Eur. J. Med. Chem."},{"key":"63397_CR36","doi-asserted-by":"publisher","first-page":"25497","DOI":"10.1074\/jbc.M115.681445","volume":"290","author":"SM Ebert","year":"2015","unstructured":"Ebert, S. M. et al. Identification and small molecule inhibition of an activating transcription factor 4 (ATF4)-dependent pathway to age-related skeletal muscle weakness and atrophy. J. Biol. Chem. 290, 25497\u201325511 (2015).","journal-title":"J. Biol. Chem."},{"key":"63397_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0278-6915(02)00205-3","volume":"41","author":"M Friedman","year":"2003","unstructured":"Friedman, M., Henika, P. R. & Mackey, B. E. Effect of feeding solanidine, solasodine and tomatidine to non-pregnant and pregnant mice. Food Chem. Toxicol. 41, 61\u201371 (2003).","journal-title":"Food Chem. Toxicol."},{"key":"63397_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/5261803","volume":"2017","author":"CY Kuo","year":"2017","unstructured":"Kuo, C. Y. et al. Tomatidine Attenuates Airway Hyperresponsiveness and Inflammation by Suppressing Th2 Cytokines in a Mouse Model of Asthma. Mediators Inflamm. 2017, 1\u20139 (2017).","journal-title":"Mediators Inflamm."},{"key":"63397_CR39","doi-asserted-by":"crossref","unstructured":"Dorsaz, S. et al. Identification and Mode of Action of a Plant Natural Product Targeting Human Fungal Pathogens. Antimicrob. Agents Chemother. 61 (2017).","DOI":"10.1128\/AAC.00829-17"},{"key":"63397_CR40","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1021\/jf204197r","volume":"60","author":"Y Fujiwara","year":"2012","unstructured":"Fujiwara, Y. et al. Tomatidine, a tomato sapogenol, ameliorates hyperlipidemia and atherosclerosis in ApoE-deficient mice by inhibiting acyl-CoA:cholesterol acyl-transferase (ACAT). J. Agric. Food Chem. 60, 2472\u20132479 (2012).","journal-title":"J. Agric. Food Chem."},{"key":"63397_CR41","first-page":"11010","volume":"0","author":"S Song","year":"1007","unstructured":"Song, S. et al. Tomatidine inhibits tumor necrosis factor-\u03b1-induced apoptosis in C 2 C 12 myoblasts via ameliorating endoplasmic reticulum stress. Mol. Cell. Biochem. 0, 11010\u201317 (1007).","journal-title":"Mol. Cell. Biochem."},{"key":"63397_CR42","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1099\/vir.0.000144","volume":"96","author":"MKS Van Duijl-Richter","year":"2015","unstructured":"Van Duijl-Richter, M. K. S., Blijleven, J. S., van Oijen, A. M. & Smit, J. M. Chikungunya virus fusion properties elucidated by single-particle and bulk approaches. J. Gen. Virol. 96, 2122\u20132132 (2015).","journal-title":"J. Gen. Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63397-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63397-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63397-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:20:11Z","timestamp":1670318411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-63397-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,14]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["63397"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-63397-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,14]]},"assertion":[{"value":"29 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6364"}}